Skip to main content
. 2019 Oct 18;14:2377–2384. doi: 10.2147/COPD.S222803

Table 1.

Baseline Demographics And Characteristics Of Patients Enrolled In The HOmeVent Registry By The Presence Of Hypercapnia Based On Carbon Dioxide Pressure Cut-Off Values Of ≥45 And ≥50 mmHg

Hypercapnia (PaCO2 ≥45 mmHg) Hypercapnia (PaCO2 ≥50 mmHg)
Yes (n=58) No (n=173) Yes (n=20) No (n=211)
Age, years 66.4±9.1 67.5±8.9 64.3±8.6 67.5±9.0
Male, n (%) 34 (59) 111 (64) 13 (65) 132 (63)
Body mass index, kg/m2 28.9±6.2 25.3±5.4 30.4±6.8 25.8±5.6
Smoking status, n (%)
 Never 4 (7) 11 (6) 2 (10) 13 (6)
 Current 17 (29) 45 (26) 5 (25) 57 (27)
 Former 37 (64) 117 (68) 13 (65) 141 (67)
GOLD stage 3, n (%) 21 (36) 114 (66) 8 (40) 127 (60)
GOLD stage 4, n (%) 37 (64) 59 (34) 12 (60) 84 (40)
Previous NIV, n (%)
 None 50 (86) 168 (97) 17 (85) 201 (95)
 At home 1 (2) 0 1 (5) 0
 In hospital 7 (12) 5 (3) 2 (10) 10 (5)
Disease history, n (%)
 Heart failure 8 (14) 14 (8) 2 (10) 10 (5)
 Diabetes mellitus 15 (26) 26 (15) 5 (25) 36 (17)
 Hypertension 34 (59) 91 (53) 14 (70) 111 (53)
 Coronary artery disease 9 (16) 25 (14) 2 (10) 32 (15)
 Depression 8 (14) 22 (13) 4 (20) 26 (12)
 Obstructive sleep apnea 6 (10) 14 (8) 3 (15) 17 (8)
Concomitant medication, n (%)
 Roflumilast 11 (19) 18 (12) 5 (25) 24 (11)
 ß2-agonists 55 (95) 155 (90) 19 (95) 191 (91)
 Anticholinergics 52 (90) 152 (88) 18 (90) 186 (88)
 Methylxanthines 7 (12) 19 (11) 2 (10) 24 (11)
 Inhaled corticosteroids 28 (48) 89 (51) 8 (40) 109 (52)
 Systemic corticosteroids 2 (3) 8 (5) 2 (10) 8 (4)
 Inhaled + systemic corticosteroids 0 3 (2) 0 3 (1)
Oxygen therapy, n (%)
 Day 0 2 (1) 0 2 (1)
 Night 0 1 (1) 0 1 (<1)
 Day & night 20 (34) 26 (15) 9 (45) 37 (18)
 During exertion 1 (2) 0 0 1 (<1)
 None 37 (64) 143 (83) 11 (55) 169 (80)

Abbreviations: GOLD, global initiative for obstructive lung disease; NIV, non-invasive ventilation; PaCO2, arterial carbon dioxide pressure.